Please assess the completion status of the following clinical trial:

Trial Title: 4-Week, Multiple-dose, Dose-escalating Study In Patients With Type 2 Diabetes

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SEQUENTIAL
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE1
- Number of Arms: 9.0

Eligibility Criteria:
Inclusion Criteria:~* Type 2 diabetes treated with a stable dose of metformin at least 500 mg~* HbA1c value between 7.0 and 10.5%~Exclusion Criteria:~- Type 1 diabetes or secondary forms of diabetes

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- Placebo (Type: PLACEBO_COMPARATOR): None
- PF-06882961 30 mg (Type: EXPERIMENTAL): None
- PF-06882961 100 mg (Type: EXPERIMENTAL): None
- PF-06882961 300 mg (Type: EXPERIMENTAL): None
- PF-06882961 600 mg (Type: EXPERIMENTAL): None
- PF-06882961 dose TBD Cohort 5 (Type: EXPERIMENTAL): None
- PF-06882961 dose TBD Cohort 6 (Type: EXPERIMENTAL): None
- PF-06882961 dose TBD Cohort 7 (Type: EXPERIMENTAL): None
- PF-06882961 dose TBD Cohort 8 (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).